avatrombopag avatrombopag avatrombopag, sold under the brand name doptelet, is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure. it was approved for medical use in the united states in may 2018, the european union in june 2019, and australia in january 2023. avatrombopagclinical datapronunciationa" va trom' boe pag trade namesdopteletahfs/drugs.commonographmedlineplusa618032license data eu ema: by inn us dailymed: avatrombopag pregnancycategory au: b3 routes ofadministrationby mouthatc codeb02bx08 (who) legal statuslegal status au: s4 (prescription only) us: ℞-only eu: rx-only in general: ℞ (prescription only) identifiers iupac name 1-carbamoyl]pyridin-2-yl]piperidine-4-carboxylic acid cas number570406-98-3 npubchem cid9852519drugbankdb11995 ychemspider8028230 yunii3h8gsz4sqlkeggd10306as salt: d10307chemblchembl2103883 ncomptox dashboard (epa)dtxsid30205667 chemical and physical dataformulac29h34cl2n6o3s2molar mass649.65 g·mol−13d model (jsmol)interactive image smiles c1ccc(cc1)n2ccn(cc2)c3=c(n=c(s3)nc(=o)c4=cc(=c(n=c4)n5ccc(cc5)c(=o)o)cl)c6=cc(=cs6)cl inchi inchi=1s/c29h34cl2n6o3s2/c30-20-15-23(41-17-20)24-27(37-12-10-35(11-13-37)21-4-2-1-3-5-21)42-29(33-24)34-26(38)19-14-22(31)25(32-16-19)36-8-6-18(7-9-36)28(39)40/h14-18,21h,1-13h2,(h,39,40)(h,33,34,38) ykey:ofzjkcqenfpzbh-uhfffaoysa-n ny (what is this?) it acts as a thrombopoietin receptor agonist.